Taken together, these results demonstrated that MIR20B contributes to hepatic lipid accumulation by controlling lipid oxidation, mitochondrial function and TG synthesis through changes in gene expression, further contributing to the progression of NAFLD. Here, MIR20B is linked to metabolic dysfunction-associated steatotic liver disease.